JP2023522725A5 - - Google Patents
Info
- Publication number
- JP2023522725A5 JP2023522725A5 JP2022564050A JP2022564050A JP2023522725A5 JP 2023522725 A5 JP2023522725 A5 JP 2023522725A5 JP 2022564050 A JP2022564050 A JP 2022564050A JP 2022564050 A JP2022564050 A JP 2022564050A JP 2023522725 A5 JP2023522725 A5 JP 2023522725A5
- Authority
- JP
- Japan
- Prior art keywords
- isomer
- pharmaceutically acceptable
- methylazetidine
- heptan
- azabicyclo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2020-0047190 | 2020-04-20 | ||
| KR20200047190 | 2020-04-20 | ||
| PCT/KR2021/004887 WO2021215765A1 (ko) | 2020-04-20 | 2021-04-19 | 3-아자바이사이클로알킬 유도체 및 이를 포함하는 약제학적 조성물 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023522725A JP2023522725A (ja) | 2023-05-31 |
| JP2023522725A5 true JP2023522725A5 (https=) | 2024-04-26 |
| JP7618338B2 JP7618338B2 (ja) | 2025-01-21 |
Family
ID=78232792
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022564050A Active JP7618338B2 (ja) | 2020-04-20 | 2021-04-19 | ３－アザビシクロアルキル誘導体およびこれを含む薬剤学的組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230203008A1 (https=) |
| EP (1) | EP4134366A4 (https=) |
| JP (1) | JP7618338B2 (https=) |
| KR (1) | KR102614659B1 (https=) |
| CN (1) | CN115667244B (https=) |
| TW (1) | TWI810550B (https=) |
| WO (1) | WO2021215765A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114846009B (zh) | 2019-12-24 | 2023-12-12 | 杭州中美华东制药有限公司 | 具有khk抑制作用的化合物 |
| EP4190776A4 (en) * | 2020-07-28 | 2024-02-28 | Shandong Xuanzhu Pharma Co., Ltd. | SALT FORM AND CRYSTAL FORM OF A KETOHEXOKINASE INHIBITOR AND USE THEREOF |
| JP2024501507A (ja) * | 2020-12-25 | 2024-01-12 | スーチュアン ハイスーク ファーマシューティカル カンパニー リミテッド | ケトヘキソキナーゼ阻害剤及びその用途 |
| KR20230098069A (ko) * | 2021-12-24 | 2023-07-03 | 주식회사 엘지화학 | (s)-2-(2-메틸아제티딘-1-일)피리미딘 유도체 및 이를 포함하는 약제학적 조성물 |
| CN118679155A (zh) * | 2022-02-09 | 2024-09-20 | 上海研健新药研发有限公司 | 一种khk抑制剂，其制备方法和应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016091774A1 (en) * | 2014-12-08 | 2016-06-16 | Janssen Sciences Ireland Uc | Piperidine substituted pyrazolo[1,5-a]pyrimidine derivatives with inhibitory activity on the replication of the respiratory syncytial virus (rsv) |
| SI3397631T1 (sl) * | 2015-12-29 | 2022-01-31 | Pfizer Inc. | Substituirani 3-azabiciklo(3.1.0)heksani kot zaviralci ketoheksokinaze |
| KR102558308B1 (ko) * | 2018-09-27 | 2023-07-24 | 주식회사 엘지화학 | 3-아자바이사이클로[3,1,1]헵탄 유도체 및 이를 포함하는 약제학적 조성물 |
| CN113412260B (zh) * | 2019-01-29 | 2022-08-02 | 山东轩竹医药科技有限公司 | 己酮糖激酶抑制剂及其用途 |
| JP2024501507A (ja) * | 2020-12-25 | 2024-01-12 | スーチュアン ハイスーク ファーマシューティカル カンパニー リミテッド | ケトヘキソキナーゼ阻害剤及びその用途 |
-
2021
- 2021-04-19 TW TW110113936A patent/TWI810550B/zh active
- 2021-04-19 CN CN202180036112.0A patent/CN115667244B/zh active Active
- 2021-04-19 KR KR1020210050451A patent/KR102614659B1/ko active Active
- 2021-04-19 JP JP2022564050A patent/JP7618338B2/ja active Active
- 2021-04-19 EP EP21793225.0A patent/EP4134366A4/en active Pending
- 2021-04-19 WO PCT/KR2021/004887 patent/WO2021215765A1/ko not_active Ceased
- 2021-04-19 US US17/996,634 patent/US20230203008A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023522725A5 (https=) | ||
| TWI670270B (zh) | 包含jak抑制劑之醫藥組合物 | |
| TWI526425B (zh) | 二環性γ-胺基酸衍生物之製造中間體 | |
| TWI734134B (zh) | 作為trk激酶抑制劑的大環化合物 | |
| JP7222590B2 (ja) | ３－アザビシクロ［３，１，１］ヘプタン誘導体及びこれを含む薬学的組成物 | |
| JP2025114615A (ja) | 治療薬としての細胞毒素のペプチドコンジュゲート | |
| CN113993590A (zh) | 新型egfr抑制剂 | |
| JP4881725B2 (ja) | Ｔｉｅ−２モジュレータと使用方法 | |
| JP2022541749A5 (https=) | ||
| CN105473573B (zh) | 用作激酶抑制剂的咔唑甲酰胺化合物 | |
| EP2152712A1 (en) | Amino-heterocyclic compounds | |
| RU2010150799A (ru) | НОВАЯ КРИСТАЛЛИЧЕСКАЯ И АМОРФНАЯ ФОРМА ТРИАЗОЛО(4,5-d)ПИРИМИДИНА | |
| CN103214484A (zh) | 作为两面神激酶抑制剂的杂芳基取代的吡咯并[2,3-b]吡啶和吡咯并[2,3-b]嘧啶 | |
| CN101863886A (zh) | 用作生长激素促分泌素的杂环芳香化合物 | |
| CN102076650A (zh) | 羧酸化合物 | |
| JP7618338B2 (ja) | ３－アザビシクロアルキル誘導体およびこれを含む薬剤学的組成物 | |
| JP6367545B2 (ja) | ルキソリチニブの重水素化誘導体 | |
| TW200538112A (en) | Novel compounds | |
| WO2020007322A1 (zh) | 一种靶向降解bet蛋白的化合物及其应用 | |
| CN105612162A (zh) | 作为nmda受体活性的调节剂的噻唑并嘧啶酮类 | |
| TW201249836A (en) | 4-phenylamino-6-butenamide-7-alkyloxy quinazoline derivatives, preparative method and use thereof | |
| JP6929857B2 (ja) | ６，７，８，９−テトラヒドロ−５Ｈ−ピリド［２，３−ｄ］アゼピンドーパミンＤ３リガンド | |
| WO2019109415A1 (zh) | 一种靶向降解hmgcr的化合物及其应用 | |
| TW201827406A (zh) | Ｎｒｆ２活化劑 | |
| KR20140107641A (ko) | Mogat-2 억제제로서 유용한 신규 모르폴리닐 유도체 |